
Pharma Pulse 3/27/25: Addressing Data and Patient Retention Challenges, Addressing Drug Shortages & more
The latest news for pharma industry insiders.
In a recent video interview with Applied Clinical Trials, Rachael Higgins, chief commercial officer, PicnicHealth, discussed the company’s recently released
Managing the challenge requires a multifaceted approach with all stakeholders.
Europe is fast losing its edge to China in pharmaceutical innovation, AstraZeneca Plc Chief Executive Officer Pascal Soriot warned.
Viz.ai announced new clinical data demonstrating how the Viz HCM module enables faster, accurate detection of signs of hypertrophic cardiomyopathy (HCM) to help ensure that more patients receive the care they need. Four studies, which will be presented at the American College of Cardiology’s Annual Scientific Session & Expo 2025, show the real-world impact of Viz.ai in clinical practice with earlier detection and triaging of new patients with HCM, a commonly inherited heart disease that often goes undetected.
#ICYMI: In the second part of her conversation with
By using predictive analytics and balancing digital advancement with clinical expertise, we can help patients access and afford the medicine they need to live healthier lives. Read now:
Have news you want us to share in Pharma Pulse? Reach out to Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.